ReNeuron Group (RENE)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 3.38p
   
  • Change Today:
      0.000p
  • 52 Week High: 11.13
  • 52 Week Low: 3.38
  • Currency: UK Pounds
  • Shares Issued: 57.17m
  • Volume: 0
  • Market Cap: £1.93m
  • RiskGrade: 394

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Sep-23 Interim 0.16 (3.23) (5.00)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-19 0.05 (17.23) (44.11)p n/a n/a n/a n/a 0.0%
31-Mar-20 6.07 (13.86) (34.96)p n/a n/a n/a n/a 0.0%
31-Mar-21 0.26 (13.41) (29.00)p n/a n/a n/a n/a 0.0%
31-Mar-22 0.40 (11.06) (17.00)p n/a n/a n/a n/a 0.0%
31-Mar-23 0.53 (6.66) (9.50)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Mar-24 0.65 (6.26) (9.14)p n/a n/a n/a n/a 0.0%
31-Mar-25 12.11 4.84 7.18p 0.5 n/a n/a n/a 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest n/a n/a n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

ReNeuron Group Market Data

Currency UK Pounds
Share Price 3.38p
Change Today 0.000p
% Change 0.00 %
52 Week High 11.13
52 Week Low 3.38
Volume 0
Shares Issued 57.17m
Market Cap £1.93m
RiskGrade 394

ReNeuron Group Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
67.86% above the market average67.86% above the market average67.86% above the market average67.86% above the market average67.86% above the market average
18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average18.52% above the sector average
Price Trend
90.4% below the market average90.4% below the market average90.4% below the market average90.4% below the market average90.4% below the market average
71.93% below the sector average71.93% below the sector average71.93% below the sector average71.93% below the sector average71.93% below the sector average
Income Not Available
Growth
4.89% above the market average4.89% above the market average4.89% above the market average4.89% above the market average4.89% above the market average
2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average2.70% above the sector average

ReNeuron Group Dividends

No dividends found

Trades for --2024

Time Volume / Share Price
0 @ 0.000p

Top of Page